Cargando…
Analysis of nationwide multimodal complex treatment and drug pump therapy in Parkinson's disease in times of COVID-19 pandemic in Germany
INTRODUCTION: During the first peak phase of the COVID-19 pandemic, the German Ministry of Health recommended that elective treatments should be postponed to increase hospital capacities. This has also compromised the capacity for application of specialized Parkinson's disease (PD) therapies to...
Autores principales: | Richter, Daniel, Scherbaum, Raphael, Bartig, Dirk, Gold, Ralf, Krogias, Christos, Tönges, Lars |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9761359/ https://www.ncbi.nlm.nih.gov/pubmed/33845342 http://dx.doi.org/10.1016/j.parkreldis.2021.03.006 |
Ejemplares similares
-
COVID-19 outcomes in hospitalized Parkinson’s disease patients in two pandemic waves in 2020: a nationwide cross-sectional study from Germany
por: Scherbaum, Raphael, et al.
Publicado: (2022) -
Clinical Profiles and Mortality of COVID‐19 Inpatients with Parkinson's Disease in Germany
por: Scherbaum, Raphael, et al.
Publicado: (2021) -
Hospital Admissions for Neurodegenerative Diseases during the First Wave of the COVID-19 Pandemic: A Nationwide Cross-Sectional Study from Germany
por: Scherbaum, Raphael, et al.
Publicado: (2021) -
Dynamics of Parkinson’s Disease Multimodal Complex Treatment in Germany from 2010–2016: Patient Characteristics, Access to Treatment, and Formation of Regional Centers
por: Richter, Daniel, et al.
Publicado: (2019) -
Letter to the editor: risk comorbidities of COVID-19 in Parkinson’s disease patients in Germany
por: Richter, Daniel, et al.
Publicado: (2020)